KraneShares Trust KraneShares Global Luxury Index ETF (ARCA: KLXY)

最新ニュース KraneShares Trust KraneShares Global Luxury Index ETF (ARCA:KLXY)

Consumer Cyclical

Consumer Defensive

Healthcare

Real Estate

The Fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its Underlying Index or in instruments that have economic characteristics similar to those in the Underlying Index.

Lvmh Moet Hennessy Louis Vuitton Se

Cie Financiere Richemont Sa

Deckers Outdoor Corp

Moncler Spa

Kao Corp

Pandora A/s

Tapestry Inc.

Estee Lauder Cos., Inc.

Ralph Lauren Corp. Class A

KraneShares Global Luxury Index ETF

KraneShares Trust KraneShares Global Luxury Index ETF

WIIM

CNXC

CNXC stock has given up its prior loss. Concentrix shares were trading lower after the company reported a Q2 adjusted EPS miss and narrowed its FY25 adjusted EPS guidance.

<a href="https://www.bloomberg.com/news/articles/2025-06-27/alibaba-unveils-latest-ai-service-for-images-in-push-for-users">https://www.bloomberg.com/news/articles/2025-06-27/alibaba-unveils-latest-ai-service-for-images-in-push-for-users</a>

News

General

BABA

'Alibaba Unveils Latest AI Service for Images in Push for Users'- Bloomberg

B of A Securities analyst Lorraine Hutchinson maintains ODDITY Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) with a Buy and raises the price target from $68 to $80.

Price Target

Analyst Ratings

B of A Securities Maintains Buy on ODDITY Tech, Raises Price Target to $80

Locafy Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCFY#NASDAQ">LCFY</a>) shares are skyrocketing Friday morning after the company announced a strategic partnership with a leading U.S. online reputation management platform.
What To Know: Locafy says the <a href="https://www.benzinga.com/pressreleases/25/06/g46136767/locafy-partners-with-leading-u-s-reputation-platform-plans-to-scale-deployment-of-ai-ready-search-">collaboration</a> will syndicate business listings for the partner&#8217;s clients, including real estate and mortgage professionals, across a wide range of digital directories, search engines and voice assistants.
This agreement provides Locafy with what the company says will be a significant foothold in the U.S. market and sets the stage for broader adoption of its new AI-powered search and engagement tools. 
Locafy will create &#8220;AI Search Ready&#8221; landing pages for clients, designed to be primary sources for major AI platforms like ChatGPT, Gemini and Perplexity.
&#8220;We&#8217;ve created the ultimate location-based digital marketing solution,&#8221; said Locafy CEO Gavin Burnett. He highlighted that the company&#8217;s technology not only syndicates listings but also boosts local search rankings for valuable keywords.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, LCFY shares are trading higher by 225% to $8.30 Friday morning. The stock has a 52-week high of $12.22 and a 52-week low of $2.28.
Read Also: <a href="https://www.benzinga.com/pressreleases/25/06/g46136767/locafy-partners-with-leading-u-s-reputation-platform-plans-to-scale-deployment-of-ai-ready-search-">Locafy Partners with Leading U.S. Reputation Platform &#8211; Plans to Scale Deployment of &#8220;AI-Ready&#8221; Search Solutions</a>
<h2 class="wp-block-heading">How To Buy LCFY Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Locafy&#8217;s case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock

LCFY

Locafy (LCFY) Stock Is Up Over 200% Today: What's Going On?

Nuburu Inc. (NYSEAMERICAN: BURU) announced Friday that it is making <a href="https://www.benzinga.com/pressreleases/25/06/b46137628/nuburu-advances-defense-tech-transformation-with-strategic-acquisitions-and-50m-military-deploymen" target="_blank" rel="noreferrer noopener">steady progress</a> in its strategic pivot toward defense and security technologies, which is highlighted by its planned acquisition of Italy-based Tekne SpA. The stock rallied following the announcement.
The deal, currently under review through Italy&#8217;s Golden Power process, is progressing as expected, with indications pointing to a favorable outcome.
Executive Chairman Alessandro Zamboni called Tekne&#8217;s &#8220;Tactical Bubble&#8221; a critical component in Italy&#8217;s military modernization. 
Also Read: <a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/45909938/optics-rebound-in-sight-j-p-morgan-boost-targets-on-coherent-lumentum-amid-tec" target="_blank" rel="noreferrer noopener">Optics Rebound In Sight: J.P. Morgan Boost Targets On Coherent, Lumentum Amid Tech Shift Easing</a>
The real-time battlefield system enhances communication, decision-making, and situational awareness across deployed units. It features integrated defenses against threats such as drones and electromagnetic interference.
Valued at over €50 million euros (approximately $58.5 million), Tekne&#8217;s ongoing contract with the Italian Ministry of Defense includes full deployment of the Tactical Bubble platform, which was recently showcased in large-scale exercises &#8220;Stella Alpina&#8221; and &#8220;Scudo 25.&#8221;
Alongside the Tekne deal, Nuburu is also advancing the acquisition of a SaaS startup designed to bolster cyber and operational resilience in sensitive infrastructure. Both transactions remain subject to regulatory and shareholder approval, with due diligence and audits underway.
Zamboni said the progress validates Nuburu&#8217;s strategy to diversify beyond laser tech and into high-growth verticals like defense-tech and homeland security. The company is also investing in emerging technologies, including Agentic AI while exploring fintech integration through its partnership with Supply@ME Capital Plc.
Related ETFs: SPDR S&amp;P Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XAR#NYSE">XAR</a>), iShares U.S. Aerospace &amp; Defense ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITA#BATS">ITA</a>).
Price Action: BURU shares are trading higher by 16.29% at $0.40 on Friday&#8217;s last check.
Read Next:
<a href="https://www.benzinga.com/news/politics/25/06/46111425/natos-new-5-target-for-defense-a-win-for-trump-carney-turns-to-critical-minerals" target="_blank" rel="noreferrer noopener">NATO&#8217;s New 5% Target For Defense A Win for Trump; Carney Turns To Critical Minerals</a>
Image by DC Studio via Shutterstock

Movers

Tech

BURU

iShares Dow Jones US Aerospace & Defense Index Fund

Why Is Nuburu Stock Soaring On Friday?

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Citigroup analyst George Gianarikas downgraded the rating for Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) from Buy to Hold and lowered the price target from $22 to $14. Lyft shares closed at $15.85 on Thursday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Canaccord Genuity analyst George Gianarikas downgraded Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) from Buy to Hold and cut the price target from $90 to $84. Uber shares closed at $93.12 on Thursday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stephens &amp; Co. analyst Trey Grooms downgraded GMS Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMS#NYSE">GMS</a>) from Overweight to Equal-Weight and maintained the price target of $95. GMS shares closed at $98.54 on Thursday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird analyst David George downgraded Bank of America Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) from Outperform to Neutral and maintained the price target of $52. Bank of America shares closed at $47.46 on Thursday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying UBER stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/UBER/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="552" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27101911/image-426-1024x552.png" alt="" class="wp-image-965002" style="width:612px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27101911/image-426-1024x552.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27101911/image-426-300x162.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27101911/image-426-768x414.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27101911/image-426.png 1153w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46115042/top-2-tech-and-telecom-stocks-you-may-want-to-dump-in-june">Top 2 Tech And Telecom Stocks You May Want To Dump In June</a> </li>
</ul>
Photo via Shutterstock

Downgrades

Markets

Trading Ideas

LYFT

UBER

This Uber Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday

Bone Biologics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBLG#NASDAQ">BBLG</a>) stock is trading higher on Friday, with a session volume of 17.22 million compared to the average volume of 38.795K <a target="_blank" href="https://www.benzinga.com/pro/feature/newsfeed" rel="noreferrer noopener">as per data from Benzinga Pro</a>.
The company filed a patent application with the U.S. Patent and Trademark Office (USPTO) for its <a href="https://www.benzinga.com/pressreleases/25/06/b46135732/bone-biologics-files-patent-application-for-bone-regeneration-technology" target="_blank" rel="noreferrer noopener">preclinical NELL-1 protein</a>.
Bone Biologics is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures. It additionally has rights to trauma and osteoporosis applications.
The patent application is directed to compositions of rhNELL-1 polypeptide and uses thereof for treating bone conditions.
&#8220;This patent application marks a major milestone in our mission to bring effective treatments to spine fusion patients,&#8221; said Jeffrey Frelick, CEO of Bone Biologics.
If approved, the patent application will strengthen Bone Biologics&#8217; intellectual property portfolio and support the company&#8217;s strategic plan to advance the clinical development program.
Additionally, on Friday, Bone Biologics priced its public offering of 1.25 million shares, Series D warrants to purchase up to 1.25 million shares of common stock, and Series E short-term warrants to purchase up to 1.25 million at $4 per share and accompanying warrants.
The Series D and Series E warrants will have an exercise price of $4 per share.
Total gross proceeds are expected to be $5.0 million. If fully exercised on a cash basis, the warrants could generate $10 million in additional gross proceeds to the company.
The company plans to use the proceeds to fund clinical trials, maintain and extend its patent portfolio and for working capital and other general <a href="https://www.benzinga.com/pressreleases/25/06/b46138329/bone-biologics-announces-pricing-of-5-0-million-public-offering" target="_blank" rel="noreferrer noopener">corporate purposes.</a>
On Thursday, Bone Biologics said it regained compliance with the minimum bid price requirement <a href="https://www.benzinga.com/pressreleases/25/06/b46127829/bone-biologics-regains-compliance-with-nasdaq-continued-listing-requirements" target="_blank" rel="noreferrer noopener">under the Nasdaq Listing</a>.
Earlier this month, Bone Biologics announced a reverse stock split of its shares of common stock <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/b45811307/bone-biologics-announces-1-for-6-reverse-stock-split" rel="noreferrer noopener">at a ratio of 1-for-6</a>.
BBLG Price Action: Bone Biologics stock is up 20.31% at $5.01 at publication on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46137965/crwv-corz-potential-deal-could-unlock-2-8-billion-hidden-value-for-bitcoin-miner-says-morgan-stanley" target="_blank" rel="noreferrer noopener">CRWV–CORZ Potential Deal Could Unlock $2.8 Billion Hidden Value For Bitcoin Miner, Says Morgan Stanley</a></li>
</ul>
Photo: Shutterstock

Health Care

Financing

Offerings

BBLG

Why Is Bone Biologics Stock Surging On Friday?

B of A Securities analyst Bryan Spillane downgrades Molson Coors Beverage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) from Buy to Neutral and lowers the price target from $65 to $50.

B of A Securities Downgrades Molson Coors Beverage to Neutral, Lowers Price Target to $50

Financial backers invested significantly in artificial intelligence ventures during late June&#8217;s third week of 2025, defying broader economic jitters that plagued traditional markets. Funding announcements and corporate acquisitions revealed investors&#8217; bullish outlook on AI&#8217;s potential. The money trail winds fascinatingly through medical breakthroughs and sophisticated data interpretation frameworks, illuminating where visionary capital finds fertile ground in this explosive technological frontier..
Let's dig in.
<h2 class="wp-block-heading">Healthcare AI Leads the Charge with Major Funding Rounds</h2>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="585" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/26221753/Depositphotos_790097468_XL-1024x585.jpg" alt="" class="wp-image-14965" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/26221753/Depositphotos_790097468_XL-1024x585.jpg 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/26221753/Depositphotos_790097468_XL-300x172.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/26221753/Depositphotos_790097468_XL-768x439.jpg 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/26221753/Depositphotos_790097468_XL.jpg 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Source: DepositPhotos License</figcaption></figure>
<h3 class="wp-block-heading">Tennr's $101 Million Raise: A Landmark for AI in Health/Medical</h3>
In a development that sent ripples through healthcare innovation circles, NYC-based startup <a href="https://finance.yahoo.com/news/exclusive-health-tech-startup-tennr-110000598.html">Tennr has locked down a jaw-dropping $101 million war chest</a>, establishing itself as this quarter&#8217;s darling of medical AI investment. Institutional Venture Partners (IVP) spearheaded the initiative alongside Andreessen Horowitz, while five additional deep-pocketed backers jumped aboard, betting heavily on Tennr&#8217;s revolutionary clinical intelligence systems.
Tennr&#8217;s breakthrough platform harnesses computational intelligence to demolish inefficiencies plaguing medical workflows while dramatically boosting patient health outcomes, tackling entrenched problems that have frustrated healthcare delivery for decades. This massive financial endorsement highlights growing recognition that intelligent algorithms might finally crack healthcare&#8217;s most stubborn challenges, from spotting elusive diagnoses to crafting personalized treatment protocols.
&#8220;Healthcare represents perhaps the most tantalizing frontier awaiting AI&#8217;s transformative touch,&#8221; observed Dr. Sarah Chen, whose healthcare technology analyses at Meridian Research shape industry perspectives. &#8220;Smart money recognizes that solutions like Tennr&#8217;s could simultaneously slash ballooning costs while elevating care standards—a virtually unprecedented combination in our complex medical ecosystem.&#8221;
<h3 class="wp-block-heading">RevelAi Health Captures Strategic $3.1M for Medical Intelligence Innovations</h3>
Meanwhile, Durham&#8217;s promising upstart <a href="https://community.hlth.com/insights/news/revelai-health-raises-3-1m-to-scale-ai-care-for-musculoskeletal-health-2025-06-23">RevelAi Health secured $3.1 million</a> to accelerate its sophisticated medical AI tools. With Ulu Ventures and Symphonic Capital leading the charge, RevelAi focuses on crafting predictive systems that empower healthcare providers to identify vulnerable patients before critical deterioration occurs—potentially preserving countless lives while slashing unnecessary hospitalization expenses.
Musculoskeletal disorders account for the largest portion of healthcare spending in the U.S., exceeding $420 billion each year. Coupled with an anticipated shortage of as many as 86,000 physicians by 2036, there is an urgent need for effective solutions. 
Christian Pean, MD, the CEO and founder of RevelAi Health, highlighted that musculoskeletal care is evolving from individual appointments to a focus on population-level accountability, particularly as clinical teams become increasingly stretched. RevelAi assists organizations in managing this transition.
<h2 class="wp-block-heading">Data Analytics Platforms Secure Strategic Investments</h2>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="512" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/26221936/Depositphotos_795812148_XL-1024x512.jpg" alt="" class="wp-image-14966" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/26221936/Depositphotos_795812148_XL-1024x512.jpg 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/26221936/Depositphotos_795812148_XL-300x150.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/26221936/Depositphotos_795812148_XL-768x384.jpg 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/26221936/Depositphotos_795812148_XL.jpg 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Source: DepositPhotos License</figcaption></figure>
<h3 class="wp-block-heading">PreciseDx's $11 Million for AI-Powered Data &amp; Analytics</h3>
The analytics segment has witnessed equally impressive capital flows, exemplified by <a href="https://www.precisedx.ai/news/precisedx-continues-path-to-commercial-launch-secures-additional-funding-and-announces-new-leadership">PreciseDx&#8217;s recent $11 million funding triumph</a>. This NYC-based innovator attracted Eventide Asset Management, laboratory giant LabCorp, and seven additional investors captivated by their groundbreaking diagnostic platform.
PreciseDx has pioneered techniques leveraging computational intelligence to scrutinize pathological imagery, empowering clinicians to make precise diagnostic and treatment determinations. Their approach embodies the growing symbiosis between human medical expertise and machine learning capabilities, where algorithms enhance rather than supplant professional judgment.
<h3 class="wp-block-heading">Typedef's $5.5 Million to Enhance AI Analytics</h3>
Not far behind in this arena, San Mateo&#8217;s promising contender <a href="https://techstartups.com/2025/06/18/typedef-emerges-from-stealth-with-5-5m-to-turn-ai-prototypes-into-production-grade-pipelines/">Typedef has attracted $5.5 million</a> to revolutionize analytics frameworks, backed by Pear VC alongside Verissimo Ventures. Typedef&#8217;s approach helps organizations navigate bewilderingly complex data environments, extracting actionable business intelligence from information chaos. Their vision of democratizing sophisticated analytics through intelligent systems has resonated powerfully with investors hunting for enterprise solutions with exponential growth potential.
<h2 class="wp-block-heading">Niche Innovators Capture Specialized Market Opportunities</h2>
<h3 class="wp-block-heading">London's Rezilien: Pioneering AI in Culture</h3>
Beyond headline-grabbing investment rounds, emerging pioneers are securing strategic funding for specialized applications. London-based Rezilien develops sophisticated algorithms focused on organizational culture—that critical yet frequently overlooked dimension of business performance. By deploying machine learning to decode workplace interactions and emotional undercurrents, Rezilien helps companies cultivate resilient, high-performing organizational ecosystems. The company took in an <a href="https://ukbaa.org.uk/blog/2025/06/19/rezilien-secures-pre-seed-funding-to-pioneer-human-adaptive-intelligence-thanks-to-foundercatalyst/">undisclosed pre-seed funding infusion</a>.&nbsp;
<h3 class="wp-block-heading">oNabu's $1 Million Raise: Combining Agile Coaching and AI</h3>
Meanwhile, Wilmington-based <a href="https://bridgemena.com/13514/">oNabu has secured $1 million</a> for its unique combination of agile coaching and artificial intelligence. The company&#8217;s platform helps development teams optimize their workflows and improve productivity through AI-driven insights and recommendations. This investment highlights the growing trend of applying AI to improve software development processes themselves – a meta-application that could yield significant efficiency gains across the tech industry.
<h2 class="wp-block-heading">Strategic Acquisitions Signal Industry Consolidation</h2>
<h3 class="wp-block-heading">Ascendion Acquires Moodys Northwest Consulting</h3>
The AI landscape isn&#8217;t just characterized by funding activities; strategic acquisitions are reshaping the competitive environment as well. A notable example is <a href="https://www.roi-nj.com/2025/06/19/tech/ascendion-buys-moodys-northwest-consulting-to-strengthen-product-leadership-in-ai-era/">Ascendion&#8217;s strategic acquisition of Sammamish-based Moodys Northwest Consulting</a>, which represents several key industry trends.
The acquisition brings multiple benefits in terms of market consolidation, including enhanced consulting capabilities in AI implementation, expanded geographic presence and market access, combined intellectual property and technical expertise, strengthened talent pool and human capital, and improved service delivery capabilities. 
<h3 class="wp-block-heading">CONSOR Engineers' Purchase of VERSA Infrastructure</h3>
Similarly, <a href="https://www.businesswire.com/news/home/20250618780213/en/Consor-Acquires-Versa-Infrastructure">CONSOR Engineers has acquired VERSA Infrastructure</a> from Houston, Texas, integrating VERSA&#8217;s AI-powered civil engineering solutions into its broader service portfolio. This acquisition reflects the growing trend of traditional engineering firms incorporating AI capabilities to maintain competitive advantage in increasingly technology-driven markets.
&#8220;These acquisitions represent a maturation phase in the AI market,&#8221; explains Marcus Thompson, technology M&amp;A advisor at Blackstone Capital. &#8220;We&#8217;re seeing larger enterprises strategically absorbing AI innovators to enhance their core offerings rather than trying to develop these capabilities in-house. This trend is likely to accelerate as AI technologies prove their value across different industry verticals.&#8221;
<h2 class="wp-block-heading">What These Trends Mean For AI-Focused Investors</h2>
The wave of recent funding and acquisition activity highlights several key takeaways for investors seeking durable returns in AI:
<ol class="wp-block-list">
<li>Health and Medical AI Remain Prime Targets: The largest and most competitive funding rounds concentrate here, indicating a blend of high societal impact and commercial promise. Savvy investors should assess companies with solid clinical validation and scalable business models. </li>
<li>Data &amp; Analytics Firms Continue to Attract Capital: Especially those that can seamlessly integrate into enterprise workflows and deliver actionable intelligence. The partnership between financial and strategic investors suggests a dual thrust: financial growth and operational implementation. </li>
<li>Diverse Applications Expand AI's Reach: AI's adoption in culture, agile coaching, and infrastructure indicates a widening market footprint. Investors should diversify their interests to capture value beyond conventional verticals. </li>
<li>Acquisitions Signal Market Consolidation: Strategic buys by consultancy and engineering firms indicate a phase where integration of AI technology deepens, reducing fragmentation. This trend can create exit opportunities or synergistic growth for investors. </li>
<li>Investor Mix Reflects Confidence and Maturity: Participation by top-tier VCs, asset managers, and corporate investors confirms the sector is entering a phase of validated opportunity, beyond speculative enthusiasm.</li>
</ol>
<h2 class="wp-block-heading">Looking Ahead: AI Investment Trends to Watch</h2>
As we move forward, several trends are likely to shape the AI investment landscape. The integration of AI with other emerging technologies like quantum computing and blockchain could create new investment opportunities at these technological intersections.
Regulatory developments, particularly around AI ethics and governance, will increasingly influence investment decisions as companies that proactively address these concerns may gain competitive advantages in sensitive markets.
Geographic diversification of AI investments is also likely to continue, with more capital flowing to AI innovators outside traditional tech hubs as talent and innovation become increasingly distributed globally.
For AI investors, staying attuned to these funding patterns and strategic moves will be essential for identifying the next wave of opportunities in this dynamic and rapidly evolving technology landscape.
Feature Image Source: AI-Generated by Andre Bourque

Opinion

Healthcare AI Draws Major Funding, Bucking Market Uncertainty

Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) announced on Friday that it has <a href="https://www.benzinga.com/pressreleases/25/06/n46137893/cyngn-inc-announces-17-2-million-registered-direct-offering" target="_blank" rel="noreferrer noopener">agreed to sell</a> 2.29 million shares at $7.50 per share under a registered direct offering with a single institutional investor.
The company&#8217;s aggregate gross proceeds will likely be approximately&nbsp;$17.2 million.
The autonomous vehicle solutions company expects to use the net proceeds from the offering for general corporate purposes and working capital.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/06/46119135/tesla-set-for-rebound-thanks-to-robotaxis-and-strong-cash-flow-analyst" rel="noreferrer noopener">Tesla Set For Rebound Thanks To Robotaxis And Strong Cash Flow: Analyst</a>
The stock rose by over 70% in Friday&#8217;s trading.
Cyngn held $16.3 million in <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/n45265772/cyngn-reports-2025-first-quarter-financial-resultshttps://www.benzinga.com/pressreleases/25/05/n45265772/cyngn-reports-2025-first-quarter-financial-results" rel="noreferrer noopener">cash and equivalents</a> as of&nbsp;March 31, 2025.
On Thursday, Cyngn <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/46116924/cyngn-stock-soars-135-after-partnering-with-nvidia-to-showcase-autonomous-industrial-vehicles" rel="noreferrer noopener">announced its partnership</a>&nbsp;with&nbsp;Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)&nbsp;to power next-gen autonomous vehicles for industrial applications. Following the update, Cyngn stock climbed over 290%.
The company was selected among a few robotics innovators using Nvidia Isaac technologies to accelerate safe, scalable autonomy across dynamic, real-world environments.
Cyngn&#8217;s stock plunged 99% over the past year as the company faced financial struggles and doubts about meeting Nasdaq&#8217;s minimum bid price. It fell short of revenue and EPS expectations for four consecutive quarters but regained compliance with the Nasdaq in March 2025.
Price&nbsp;Action:&nbsp;CYN stock is up 72.1% at $23.35 at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46137326/alibabas-ai-model-outperforms-radiologists-in-early-gastric-cancer-detection" target="_blank" rel="noreferrer noopener">Alibaba&#8217;s AI Model Outperforms Radiologists In Early Gastric Cancer Detection</a></li>
</ul>
Photo: Shutterstock

NVDA

What Is Going On With Autonomous Vehicle Solutions Provider Stock Cyngn On Friday?

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>TD Securities analyst John Mould initiated coverage on Fortis Inc. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/FTS#TSX">FTS</a>) with a Buy rating and announced a price target of C$74. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Peter Abramowitz initiated coverage on Armada Hoffler Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHH#NYSE">AHH</a>) with a Buy rating and announced a price target of $8. Armada Hoffler Properties shares closed at $6.96 on Thursday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>William Blair analyst Ryan Merkel initiated coverage on James Hardie Industries plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHX#NYSE">JHX</a>) with an Outperform rating. James Hardie Industries shares closed at $25.77 on Thursday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Hovde Group analyst David Bishop initiated coverage on S&amp;T Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBA#NASDAQ">STBA</a>) with a Market Perform rating and announced a price target of $41. S&amp;T Bancorp shares closed at $38.21 on Thursday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird analyst Justin Hauke initiated coverage on EMCOR Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EME#NYSE">EME</a>) with an Outperform rating and announced a price target of $560. EMCOR Group shares closed at $510.99 on Thursday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying EME stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/EME/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="543" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27101236/image-425-1024x543.png" alt="" class="wp-image-964985" style="width:647px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27101236/image-425-1024x543.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27101236/image-425-300x159.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27101236/image-425-768x407.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27101236/image-425.png 1151w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46115042/top-2-tech-and-telecom-stocks-you-may-want-to-dump-in-june">Top 2 Tech And Telecom Stocks You May Want To Dump In June</a></li>
</ul>

Initiation

STBA

TSX:FTS

This EMCOR Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Baird analyst Ghansham Panjabi maintains H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) with a Outperform and raises the price target from $60 to $75.

Baird Maintains Outperform on H.B. Fuller, Raises Price Target to $75

<a href="https://www.benzinga.com/government/regulations/25/02/43903335/financial-crime-weekly-1-4-billion-ethereum-stolen-in-largest-crypto-hack-ever-sec-creates-cyber-and-emerging-technologies-unit">Crypto hacks and exploits</a> have surged to record levels in the first half of 2025, with total losses exceeding $2.1 billion across at least 75 incidents, according to blockchain intelligence firm TRM Labs.
What Happened: The <a href="https://www.trmlabs.com/resources/blog/h1-2025-crypto-hacks-and-exploits-a-new-record-amid-evolving-threats">figure</a> marks the highest-ever total for the first half of a year, surpassing the previous record set in the first half of 2022 by around 10%.
The largest single event was the $1.5 billion hack of Dubai-based crypto exchange Bybit in February, which TRM Labs attributes to North Korea. 
The Bybit breach alone accounted for nearly 70% of total losses this year, significantly inflating the average hack size to nearly $30 million, double that of H1 2024.
TRM Labs reported that North Korean-linked groups were responsible for approximately $1.6 billion in stolen assets during H1 2025, solidifying the country&#8217;s position as the most active nation-state actor in the crypto space. 
The report suggested that these thefts are a strategic part of North Korea's broader efforts to finance its national objectives, including its nuclear weapons program.
Why It Matters: While North Korea continues to dominate, the report also highlighted other state-sponsored attacks.
One notable incident involved the Israel-linked group Gonjeshke Darande (Predatory Sparrow), which reportedly hacked Iranian crypto exchange Nobitex for over $90 million in June. 
The attackers transferred stolen funds to unspendable addresses, signaling a symbolic or political motivation rather than financial gain.
Also Read: <a href="https://www.benzinga.com/markets/25/06/46083555/whats-driving-goldman-sachs-and-citadel-into-crypto-the-135m-digital-asset-funding-round-explained">What&#8217;s Driving Goldman Sachs And Citadel Into Crypto? The $135M Digital Asset Funding Round Explained</a>
Infrastructure attacks, such as private key and seed phrase thefts, accounted for over 80% of stolen funds in the first half of 2025. 
These breaches, often enabled by social engineering or insider access, were significantly larger on average than other attack types. 
Protocol exploits, including flash loan and re-entrancy attacks, made up another 12% of total losses.
TRM Labs emphasized that the rising involvement of state actors marks a turning point in the crypto security landscape. 
The report urged the industry to strengthen basic cybersecurity practices, including multi-factor authentication, cold storage, and regular audits, while also improving defenses against sophisticated nation-state threats.
The report stressed that coordinated international efforts will be essential to counter this escalating threat. 
Stronger partnerships between law enforcement, financial intelligence units, and blockchain analytics firms will be necessary to track stolen assets and hold perpetrators accountable.
TRM Labs concluded that as digital assets become more intertwined with global financial systems and national security, crypto hacks may increasingly be used not just for financial gain but as instruments of geopolitical strategy.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46081761/bitcoin-dominance-tops-65-but-altcoin-season-is-close-trader-says">Bitcoin Dominance Tops 65% But &#8216;Altcoin Season&#8217; Is Close, Trader Says</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

North Korean Hackers Top Crypto Exploits List, But Another State May Surprise You

Baird analyst Timothy Wojs maintains Acuity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>) with a Neutral and raises the price target from $315 to $335.

Baird Maintains Neutral on Acuity, Raises Price Target to $335

FIGXU

Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

B. Riley Financial, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RILY#NASDAQ">RILY</a>) shares are trading higher on Friday following the announcement <a href="https://www.benzinga.com/pressreleases/25/06/n46136255/b-riley-financial-announces-the-117-8-million-sale-of-glassratner-to-torquest-partners" target="_blank" rel="noreferrer noopener">of a strategic divestiture.</a>
The company sold its advisory divisions, GlassRatner Advisory &amp; Capital Group, LLC and B. Riley Farber Advisory Inc., to funds managed by TorQuest Partners for $117.8 million.
This deal is expected to result in a second-quarter gain of approximately $66 million for B. Riley.
According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>, B. Riley stock has lost over 82% in the past year.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45527790/goldman-sachs-bets-on-jpmorgan-praises-market-share-gains-efficiency" rel="noreferrer noopener">Goldman Sachs Bets On JPMorgan, Praises Market Share Gains, Efficiency</a>
According to Bryant Riley, chairman and co-CEO of B. Riley, this transaction is part of a renewed commitment to focus on the company&#8217;s core business segments: its middle-market investment banking division, B. Riley Securities, and its wealth management platform.
The proceeds from the sale are intended to fuel growth initiatives and strengthen the company&#8217;s financial foundation, with a primary goal of maximizing shareholder value.
GlassRatner, acquired by B. Riley in 2018, specializes in restructuring, forensic accounting and litigation consulting.
Despite a record performance last year, B. Riley decided to part ways with the unit after close collaboration with GlassRatner CEO Ian Ratner. Ratner expressed enthusiasm for GlassRatner&#8217;s &#8220;new chapter&#8221; under TorQuest&#8217;s stewardship, highlighting TorQuest&#8217;s track record of scaling firms.
Justin Catalano, a partner at TorQuest, affirmed confidence in GlassRatner&#8217;s future, noting its established industry position and growth potential. This acquisition marks TorQuest&#8217;s third platform investment from its C$2.3 billion Fund VI.
B. Riley Financial Inc. is known for its comprehensive financial solutions, which include investment banking, asset management, brokerage services, and corporate restructuring.
The firm also engages in opportunistic investments and financing of asset-backed ventures through its affiliated entities.
RILY Price Action: B. Riley shares are trading higher by 2.68% to $3.07 at publication on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46135159/us-stocks-likely-to-open-higher-as-commerce-secretary-confirms-deal-with-china-nike-worthington-steel-surge-amid-upbeat-earnings" target="_blank" rel="noreferrer noopener">US Stocks Likely To Open Higher As Commerce Secretary Confirms Deal With China: Nike, Worthington Steel Surge Amid Upbeat Earnings</a></li>
</ul>
Photo: Shutterstock

Equities

RILY

B. Riley Cashes In $66 Million Gain With GlassRatner Sale, Refocuses On Core Business

Wells Fargo analyst Joe Quatrochi maintains Advanced Energy Indus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEIS#NASDAQ">AEIS</a>) with a Equal-Weight and raises the price target from $110 to $130.

AEIS

Wells Fargo Maintains Equal-Weight on Advanced Energy Indus, Raises Price Target to $130

Baird analyst David George downgrades Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) from Outperform to Neutral and maintains the price target from $52 to $52.

Baird Downgrades Bank of America to Neutral, Maintains Price Target to $52

Wells Fargo analyst Ken Gawrelski maintains Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Overweight and raises the price target from $78 to $116.

RBLX

Wells Fargo Maintains Overweight on Roblox, Raises Price Target to $116

Wells Fargo analyst Ken Gawrelski maintains Match Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) with a Equal-Weight and raises the price target from $31 to $32.

Comments

KraneShares Trust KraneShares Global Luxury Index ETF

ニュース

最新ニュース KraneShares Trust KraneShares Global Luxury Index ETF (ARCA:KLXY)

ニュース

パートナーシップ

ベンジンガ・グローバル